JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Scope & Guideline
Elevating standards in gastrointestinal and liver disease research.
Introduction
Aims and Scopes
- Gastrointestinal Disorders and Diseases:
Research includes studies on various gastrointestinal disorders such as inflammatory bowel disease (IBD), functional gastrointestinal disorders, and colorectal cancer, with a focus on their pathophysiology, diagnosis, and treatment. - Liver Diseases and Hepatology:
The journal publishes extensive research on liver diseases, including hepatitis B and C, liver cirrhosis, hepatocellular carcinoma, and metabolic-associated fatty liver disease, emphasizing disease mechanisms, clinical management, and therapeutic advancements. - Endoscopic Techniques and Innovations:
A significant focus is placed on the development and evaluation of endoscopic techniques, including endoscopic submucosal dissection, capsule endoscopy, and advanced imaging modalities, aimed at improving diagnostic and therapeutic outcomes. - Microbiome and Metabolism:
Research on the gut microbiome's role in gastrointestinal and liver diseases is prevalent, particularly studies exploring microbiota composition, metabolic pathways, and their implications for disease management and treatment efficacy. - Clinical Trials and Therapeutic Interventions:
The journal features clinical trial results and studies evaluating new therapeutic agents, including biologics and novel pharmacological treatments, highlighting their effectiveness and safety in managing gastrointestinal and liver conditions. - Public Health and Epidemiology:
Contributions addressing the epidemiological aspects of gastrointestinal and liver diseases, including prevalence studies, risk factors, and public health interventions, are integral to the journal's scope.
Trending and Emerging
- Metabolic Dysfunction-Associated Liver Disease (MAFLD):
Research on metabolic dysfunction-associated fatty liver disease has gained prominence, with studies exploring its pathogenesis, management strategies, and implications for patient outcomes. - Artificial Intelligence in Gastroenterology:
The integration of artificial intelligence and machine learning technologies in diagnostic processes and treatment planning has become a significant focus, enhancing the accuracy and efficiency of clinical practices. - Gut Microbiome Research:
There is an increasing emphasis on understanding the role of the gut microbiome in gastrointestinal and liver diseases, with studies investigating its impact on disease progression and treatment responses. - Personalized Medicine Approaches:
Personalized and precision medicine approaches in treating inflammatory bowel disease and hepatological conditions are emerging as a key area, reflecting a shift towards individualized patient care based on genetic and phenotypic markers. - Telehealth and Virtual Care Models:
The COVID-19 pandemic has accelerated the adoption of telehealth and virtual care models, with ongoing research evaluating their effectiveness in managing gastrointestinal diseases and improving patient access to care. - Patient-Reported Outcomes and Quality of Life:
An increasing number of studies are focusing on patient-reported outcomes and health-related quality of life, particularly in chronic conditions like IBD and liver diseases, emphasizing the importance of patient perspectives in treatment evaluation.
Declining or Waning
- Traditional Pharmacological Approaches:
There has been a noticeable reduction in studies focusing solely on traditional pharmacological treatments for gastrointestinal and liver diseases, as interest shifts towards novel therapies and precision medicine. - Surgical Techniques in Gastroenterology:
Research pertaining to conventional surgical techniques has waned, with a growing preference for minimally invasive endoscopic procedures and innovative technologies for treatment. - Epidemiological Studies of Common Conditions:
While public health remains important, there is a decline in the volume of epidemiological studies focusing solely on common gastrointestinal conditions, as researchers increasingly target specific populations or emerging diseases. - General Reviews of Established Guidelines:
The publication of general reviews summarizing established clinical guidelines has decreased, as the focus has shifted towards innovative practices and real-world applications of new treatments.
Similar Journals
Gastrointestinal Disorders
Empowering Professionals with Cutting-Edge GI ResearchGastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.
Gastroenterologia y Hepatologia
Pioneering research for better digestive disease outcomes.Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.
JGH Open
Advancing Gastroenterology and Hepatology Knowledge for AllJGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.
Clinical Gastroenterology and Hepatology
Innovating Insights for Digestive HealthClinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.
DIGESTIVE AND LIVER DISEASE
Connecting professionals through groundbreaking studies.DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.
Saudi Journal of Gastroenterology
Empowering knowledge for better digestive health.The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.
Cellular and Molecular Gastroenterology and Hepatology
Advancing knowledge in gastrointestinal and liver health.Cellular and Molecular Gastroenterology and Hepatology, published by Elsevier Inc, is a premier Open Access journal dedicated to advancing the understanding and treatment of gastrointestinal and liver diseases. Since its inception in 2015, this journal has established itself as a leading publication within its field, boasting impressive metrics with a 2023 Q1 ranking in both Gastroenterology and Hepatology. It ranks #10 out of 167 in Gastroenterology and #11 out of 82 in Hepatology on Scopus, placing it in the 94th and 87th percentiles, respectively. This journal aims to disseminate high-quality, peer-reviewed research that fosters innovative solutions for clinical challenges, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access, all published content is readily available to a global audience, ensuring that critical findings in cellular and molecular biology related to gastroenterology and hepatology reach those who can benefit the most from the latest advances in the field. For more information, please visit us at our address in San Diego, CA, or explore our articles online.
Expert Review of Gastroenterology & Hepatology
Navigating the Evolving Landscape of Digestive MedicineExpert Review of Gastroenterology & Hepatology is a premier journal published by Taylor & Francis Ltd that aims to bridge the gap between clinical practice and research in the fields of gastroenterology and hepatology. Established in 2007, this journal has rapidly gained recognition, boasting a Q1 ranking in Gastroenterology and a Q2 ranking in Hepatology for 2023, while achieving impressive Scopus rankings of 31st and 25th respectively in these disciplines, placing it within the top 81st and 70th percentiles. The journal’s objective is to provide a comprehensive platform for the latest developments, innovative treatments, and critical reviews, catering to researchers, healthcare professionals, and students alike. Located in the United Kingdom, the journal does not operate under an open access model but ensures that its content is accessible to a global audience through institutional subscriptions. By consistently publishing high-impact reviews and articles, Expert Review of Gastroenterology & Hepatology solidifies its role as a vital resource in advancing knowledge and clinical practice within these challenging and evolving fields.
Gastroenterology Research and Practice
Elevating Standards in Gastrointestinal ResearchGastroenterology Research and Practice is a leading Open Access journal dedicated to advancing the field of gastroenterology and hepatology. Published by HINDAWI LTD, this journal offers a platform for researchers, clinicians, and healthcare professionals to share their findings and insights on cutting-edge topics in digestive health. With an ISSN of 1687-6121 and an E-ISSN of 1687-630X, it has established its significance within the academic community, evidenced by its ranking in the 2023 Scopus metrics, where it is positioned in the third quartile for both gastroenterology and hepatology disciplines. The journal is recognized for disseminating high-quality, peer-reviewed articles that contribute to the understanding of gastrointestinal disorders, therapeutic advancements, and innovative practices. Since its inception as an Open Access journal in 2008, Gastroenterology Research and Practice has removed barriers to access, ensuring that vital research reaches a global audience. This ongoing commitment to increasing accessibility, alongside its continuous publication from 2009 to 2024, underscores its importance as a resource for the academic and clinical communities striving to improve patient outcomes in digestive diseases.
Gut and Liver
Pioneering research for a healthier tomorrow.Gut and Liver is a prestigious peer-reviewed journal dedicated to advancing the fields of Gastroenterology and Hepatology. Published by the EDITORIAL OFFICE GUT & LIVER in South Korea, this Open Access journal has been disseminating valuable research findings since 2007, making critical knowledge accessible to a global audience. With an impressive 2023 impact factor that places it in Q1 rank in both Gastroenterology (#28/167) and Hepatology (#22/82), it is recognized as a leader in the medical domain. The journal covers diverse topics, including innovative therapeutic strategies, clinical practices, and groundbreaking research in liver diseases and gastrointestinal disorders, thereby playing a vital role in improving patient care and outcomes. Researchers, healthcare professionals, and students can benefit from the journal's wealth of information, designed to foster collaboration and spark new ideas within the scientific community. For further engagement with current research, readers can access issues from 2009 to 2024 and stay updated on the latest advancements in the field.